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Abstract 21 
Objectives  22 
To investigate whether and how structured feedback sessions can increase rates of 23 
appropriate antimicrobial prescribing by junior doctors.   24 
 25 
Methods  26 
This was a mixed methods study, with a conceptual orientation towards complexity and 27 
systems thinking. Fourteen junior doctors, in their first year of training, were randomised to 28 
intervention (feedback) and 21 to control (routine practice) groups in a single UK teaching 29 
hospital.  Feedback on their antimicrobial prescribing was given, in writing and via group 30 
sessions.  Pharmacists assessed the appropriateness of all new antimicrobial prescriptions two 31 
days per week for six months (46 days). The mean normalised prescribing rates of suboptimal 32 
to all prescribing were compared between groups using the t-test.  Thematic analysis of 33 
qualitative interviews with 10 participants investigated whether and how the intervention had 34 
impact.  35 
 36 
Results  37 
Data were collected on 204 prescriptions for 166 patients.  For the intervention group, the 38 
mean normalised rate of suboptimal to all prescribing was 0.32±0.36; for the control group, it 39 
was 0.68±0.36.  The normalised rate of suboptimal prescribing was significantly different 40 
between the groups (p-value=0.0005).  The qualitative data showed that individuals’ 41 
prescribing behaviour was influenced by a complex series of dynamic interactions between 42 
individual and social variables, such as interplay between personal knowledge and the 43 
expectations of others.  44 
 45 
Conclusions  46 
The feedback intervention increased appropriate prescribing by acting as a positive stimulus 47 
within a complex network of behavioural influences.  Prescribing behaviour is adaptive and 48 
can be positively influenced by structured feedback. Changing doctors’ perceptions of 49 
acceptable, typical and best practice could reduce suboptimal antimicrobial prescribing.  50 
 51 
Introduction  52 
Inappropriate or otherwise suboptimal antimicrobial prescribing is a common cause of 53 
increased patient morbidity and mortality in hospitals.1  In addition to having detrimental 54 
effects on individual patients, such suboptimal prescribing also contributes to antimicrobial 55 
resistance, which is a global public health concern2 that is referred to by some as a “super 56 
wicked challenge”.3, 4  In response to the potential consequences of this problem, a UK Five 57 
Year Antimicrobial Resistance (AMR) Strategy5 has recently been introduced, calling for 58 
increased understanding of, and response to, this issue.  Strategies designed to improve the 59 
quality of antimicrobial prescribing have been implemented widely throughout the UK.  One 60 
such example is the nationwide antimicrobial stewardship program, ‘Start Smart – then 61 
Focus”.6  This approach advocates ‘Right Drug, Right Dose, Right Time, Right Duration, 62 
Every Patient’.7   63 
 64 
Research has shown that the majority of hospital prescriptions are written by junior doctors, 65 
who are in the first two years after qualification.8  Prescribing errors occur in approximately 66 
10% of these prescriptions and a substantial proportion of those errors involve 67 
antimicrobials.9  This suggests that initiatives targeted at improving junior doctors’ 68 
prescribing behaviour may significantly improve antimicrobial prescribing in the UK.   69 
 70 
Despite recognition that structured, regular feedback is an important factor in developing 71 
expertise10 and could facilitate changes in prescribing behaviours,11, 12 several studies have 72 
highlighted that junior doctors get little feedback.13-15 Ivers and colleagues found, in their 73 
systematic review, that feedback was most effective when it was accompanied by clear 74 
targets and an action plan, in addition to performance data.16 Bertels and colleagues recently 75 
reported that junior doctors are eager to receive both individual and general feedback about 76 
prescribing errors.14  Furthermore, they found pharmacists willing to enhance the quality and 77 
quantity of the feedback they provided if time was made available.  It has been suggested, 78 
therefore, that research should focus on developing and evaluating structured methods of 79 
providing such feedback that are feasible for pharmacists to deliver and beneficial for junior 80 
doctors to receive.14  In particular, reflection as to what to do with feedback, in order to 81 
change future behaviour, is known to be as important as receiving feedback.17 Self-generated 82 
plans have been shown to improve the effectiveness of feedback.18   To date, there is a 83 
scarcity of literature reporting research that combines feedback and supporting future 84 
behaviour change with regard to prescribing. 85 
 86 
Study aim and research question 87 
Our aim was to conduct and evaluate a pharmacist-led feedback intervention for junior 88 
doctors.  The research question was: how could structured feedback affect the rate of 89 
appropriate antimicrobial prescribing amongst junior doctors, in comparison to normal 90 
practice? We addressed this question using mixed quantitative and qualitative methods, 91 
assessing appropriate antimicrobial prescribing rates and exploring how both the intervention 92 
and normal feedback practice influenced prescribers’ behaviour. Quantitative data assessed 93 
whether the intervention had an impact, whilst the qualitative data explored perceptions about 94 
what worked, when and where. It was important to include both methods because the social 95 
world is a complex one and we would not, therefore, be able to explain how or why our 96 
intervention had an effect on the basis of numeric data alone.19, 20  97 
  98 
Methods  99 
Study design 100 
This was a multi-method study, incorporating a qualitative process evaluation within a 101 
quantitative intervention study.  A single-blinded, randomised controlled trial compared the 102 
impact of a feedback intervention with normal practice on rates of junior doctors’ appropriate 103 
antimicrobial prescribing.  Qualitative interviews investigated how and why the intervention 104 
influenced prescribers’ behaviour within the context of clinical practice. 105 
 106 
Investigations as to the impact of complex interventions requires a good theoretical 107 
understanding as to the mechanisms by which change could occur.19  This is not least because 108 
lack of impact could reflect problems in implementation, rather than genuine ineffectiveness.  109 
Therefore we chose to interview participants in both the intervention and control groups, to 110 
explore the whole system of antimicrobial prescribing and the influence of both intervention 111 
and normal feedback practice, especially as doctors in the intervention group received both 112 
types of feedback, as described below. 113 
 114 
Governance approvals 115 
The study was approved by the University of Manchester Senate Ethics Committee and the 116 
University Hospital of South Manchester Research and Development Department.  All 117 
participants gave informed consent to either quantitative data collection alone, or in 118 
combination with a qualitative interview. 119 
 120 
Setting and participants 121 
The study site was a 900-bed teaching hospital in England.  All 36 first year junior doctors 122 
were sent information about the study by the Foundation Programme Director.  Initially, 29 123 
agreed to participate and were randomly assigned (using computer-generated random 124 
numbers) to either intervention or control group. At a later stage, a further six doctors 125 
expressed an interest in joining the study and, as the first intervention had already taken 126 
place, they were assigned to the control group (the rationale for allowing participants to join 127 
at a later stage is explained under ‘Results’). Only they, some members of the research team, 128 
and the pharmacist facilitating the feedback intervention knew the group allocation.  Ward 129 
pharmacists and staff on the validation panel did not know. 130 
  131 
Control feedback practice 132 
Participants in both the intervention and control groups received normal feedback practice 133 
from the ward pharmacist.  This involved pharmacists initially detecting any suboptimal 134 
antimicrobial prescribing and prescribing errors as part of their normal duties.  They then 135 
corrected minor issues themselves and discussed issues that were more significant with the 136 
doctor on duty at that time, who may not have been the original prescriber.   137 
 138 
Intervention feedback practice 139 
The intervention was designed to provide individualised, formal feedback on the 140 
appropriateness of foundation trainees’ prescribing of antimicrobials.  Confidential written 141 
feedback of the quantitative data described below was given privately to each participant at 142 
the beginning of feedback workshops by a senior pharmacist with medical education 143 
experience and training in facilitating group feedback discussions.  Each participant received 144 
data about their own antimicrobial prescribing (both appropriate and suboptimal) and, for 145 
comparison, collated information about antimicrobial prescribing in the whole intervention 146 
group.   147 
 148 
The feedback workshops were designed to increase participants’ ability to prescribe 149 
appropriately by addressing knowledge gaps, discussing social and behavioural aspects of 150 
prescribing, and encouraging reflection. Before attending, intervention group participants 151 
were asked to reflect on their individual prescribing behaviour and any problems they had 152 
experienced.  Figure 1 presents the activities that occurred during the workshops after the 153 
participants had received the feedback information.  Rather than just giving “the right 154 
answer”, the pharmacist facilitator supported and guided participants’ reflective processes.  155 
The doctors then set individual objectives as to how they were going to change their 156 
behaviour when faced with the same prescribing situations in the future.  In the follow-up 157 
workshop, participants repeated this process with further feedback information and discussed 158 
how they had acted on their earlier objectives. 159 
 160 
Quantitative data collection  161 
Ward pharmacists were asked to identify new antimicrobial prescriptions written by junior 162 
doctors on weekly census days. The following data were collected from the prescription chart 163 
or from the medical notes by a member of the research team:  164 
 165 
• Antimicrobial prescription(s) (drug, dose, frequency, route, duration, prescriber) 166 
• Any concomitant condition that would impact on the prescription (e.g. renal/hepatic 167 
function impacting on the dose or drug choice) 168 
• Any documented allergies to antimicrobials which would impact on the choice of agent 169 
• Documented indication for each prescription or whether no indication was documented 170 
 171 
In addition, the following information was collected, to understand the context of the 172 
prescribing and to allow decisions to be made as to whether the prescription was appropriate: 173 
 174 
• Whether the drug was prescribed on a ward round (consultant or registrar) or on call 175 
• Whether the infection was community or hospital acquired 176 
• Whether the prescription was for prophylaxis or treatment 177 
• Which specialty the junior doctor was working in 178 
• Whether any recommendations had been documented in the notes (e.g. from 179 
microbiologists or infectious diseases specialists) 180 
• Whether the hospital’s antimicrobial guidelines had recently been updated  181 
• Any other comments 182 
 183 
Prescriptions were categorised as “independent” if there was no evidence that they were in 184 
response to instructions from a senior or a specialist in microbiology or infectious diseases. 185 
Prescriptions that took place as a result of such instructions were termed “dependent” 186 
prescribing. 187 
 188 
Categorisation of prescribing appropriateness 189 
A validation panel, which consisted of two hospital clinicians and two clinical pharmacists 190 
with specific expertise in infection and antimicrobial prescribing, evaluated all data and 191 
judged whether treatments were appropriate or suboptimal.  Appropriateness was judged in 192 
relation to the Trust’s antimicrobial guidelines using a development of a validated algorithm 193 
developed by Willemsen and colleagues (see Table S1 (available as Supplementary data at 194 
JAC Online).21  Antimicrobial prescriptions (either for treatment or prophylaxis) were 195 
categorised using one of the following: appropriate decision, suboptimal antimicrobial 196 
choice, suboptimal prescription writing, or insufficient data to judge appropriateness.  If a 197 
prescription was suboptimal because of both choice and writing faults, it was classified in the 198 
first group, as suboptimal antimicrobial choice.  Prescriptions that were written using a non-199 
approved name (e.g. Augmentin®), rather than the generic name (according to the Trust's 200 
guidelines) were noted for feedback to the doctor.  If that was the only issue, however, it was 201 
not classed as a suboptimal prescription. 202 
 203 
Quantitative data analysis 204 
The number of appropriate and suboptimal prescriptions were categorised by type by the 205 
panel, who were blinded to the identity of the doctor and whether they were in the 206 
intervention or the control group.  The prescribing rates, both for appropriate and suboptimal 207 
prescribing, were normalised for each participant, to account for variations in prescribing 208 
activity.  Student's t-test was used to compare these normalised prescribing rates for the 209 
participants in the two groups. 210 
 211 
Qualitative data collection 212 
Participants from the control and intervention groups were recruited for interview by email. 213 
All who agreed to participate were asked about their views on antimicrobial prescribing and 214 
normal feedback practices. Ten participating doctors were interviewed; five from the 215 
intervention group and five from the control group.  Semi-structured qualitative interviews 216 
explored participants’ experiences of antimicrobial prescribing in their working practice.  217 
Participants in both groups were asked about potential influences on changes to their 218 
antimicrobial prescribing practice over their first year as a junior doctor.  Questions and 219 
prompts covered their prescribing practices and asked about their knowledge and skills, their 220 
beliefs as to how they could change their practice and their motivation to do so. In total, 233 221 
minutes of audio data were gathered, with individual interviews lasting between 14 and 35 222 
minutes.   223 
 224 
For those participants in the intervention group, we also explored their perspectives on the 225 
intervention process and outcomes, and any positive or negative views of their experiences.  226 
They were asked about the perceived impact of the intervention, such as how the feedback 227 
affected participants’ daily work practices.   228 
 229 
Qualitative data analysis 230 
The interviews were audio-recorded and transcribed verbatim.  The data were analysed using 231 
a constant comparative method. Two members of the research team (LM and MT) 232 
independently identified core themes relating to the intervention and antimicrobial 233 
prescribing in general and reached a consensus.  The themes within the data led us to 234 
examine the interrelationship between individual and social determinants of prescribing 235 
behaviour. This interpretation was discussed with a third member of the team (TD), who is an 236 
expert qualitative researcher and had remained naïve to the data.  This independent opinion of 237 
the analysis encouraged reflexivity, enabled the interpretation to be refined further, and 238 
contributed to the validity of the final interpretation. The final interpretation is presented as a 239 
diagrammatic model, supported by illustrative cases and quotations from the data. 240 
Participants are identified by number, indicating the order in which they were interviewed.  241 
Unrelated text has been removed from the quotes, as indicated by ellipses (…). 242 
 243 
Results 244 
Twenty-nine doctors were initially recruited to the study; 14 were randomised to the 245 
intervention group and 15 to the control group.  Six more doctors expressed an interest in 246 
joining the study after the first workshop had taken place and were added to the control 247 
group, which totalled 21 participants.  The decision to add these participants at a later stage 248 
was based upon the fact that data on their prescribing had already been collected and, 249 
therefore, denying them the opportunity to participate would have been unethical. It was 250 
judged that their inclusion would be unlikely to have a confounding effect if they were added 251 
to the control group.  Three of the participants randomised to the intervention group attended 252 
one workshop session, while 11 attended both workshops. 253 
 254 
Quantitative findings 255 
Data were collected on 46 census days, one day per week for eight weeks (January-February 256 
2013) and on two consecutive days per week for 20 weeks thereafter (March-July 2013).  257 
Data on antimicrobial prescribing were collected for 166 patients, 104 from medical and 62 258 
from surgical wards.  For these patients, 204 antimicrobial prescriptions were identified as 259 
having been written by junior doctors.  Seventy-five prescriptions were written by 260 
participants in the intervention group and 129 written by those in the control group. 261 
 262 
Ninety-four (46%) prescriptions were written independently (i.e. apparently based on a junior 263 
doctor’s own decision) and 110 (54%) dependently, i.e. based on instructions given by a 264 
microbiology/infectious diseases doctor or senior colleague on a ward round (Table 1).  In 265 
total, eighty-eight prescriptions (43.1%) were written appropriately and 116 (56.9%) were 266 
written suboptimally (Table 2).  Fifteen otherwise appropriate prescriptions and 15 267 
suboptimal prescriptions used a non-approved name.   268 
 269 
For the intervention group, there were 37 appropriate and 38 suboptimal prescriptions (mean 270 
normalised prescribing rate (±SD) of suboptimal to all prescribing = 0.32±0.36); for the 271 
control group, there were 51 appropriate and 78 suboptimal prescriptions (mean normalised 272 
suboptimal prescribing rate = 0.68±0.36).  The mean normalised prescribing rate of 273 
suboptimal prescribing was significantly different between the groups (p-value=0.0005).  274 
This was mostly due to differences in suboptimal prescription writing, rather than differences 275 
in suboptimal choice of antimicrobials (Table 2). 276 
 277 
Qualitative Findings 278 
 279 
In order to understand how our intervention affected participants’ behaviour, we identified 280 
other influences on the participants' antimicrobial prescribing, shown in Coding Template 1 281 
(Table 3). Coding Template 2 (also Table 3) shows themes that related specifically to the 282 
structured feedback sessions, i.e. the intervention. Following a thematic analysis, we were 283 
able to suggest a theory of prescribing behaviour and propose some mechanisms of change. 284 
Throughout this discussion of our findings, themes represented by third-level codes are 285 
highlighted in bold.  286 
 287 
Prescribing behaviour 288 
 Antimicrobial prescribing behaviour had three major components: motivation, process and 289 
evaluation (Coding Template 1, second-level codes). Each of these aspects was influenced by 290 
a complex network of individual and social variables (Coding Template 1, third-level codes). 291 
Some of these influences were primarily individual (indicated by I), whilst others were 292 
predominantly social (indicated by S). However, they were interdependent and, therefore, 293 
prescribing outcomes (i.e. written prescriptions) could not be accounted for by a purely 294 
individual or social view of behavioural determinants. This is illustrated by two case 295 
examples. One participant (Participant 04) identified lack of personal knowledge (individual 296 
factor) and conflict between colleagues (others’ expectations) and guidelines (social factors) 297 
as being barriers to optimal prescribing (Table 4, Q01). He went on to explain, in Q02, how 298 
the media and his seniors had increased his awareness of antimicrobial resistance (social 299 
influence), which motivated him to be self-aware when he was prescribing (individual 300 
factor). He perceived the benefits of careful prescribing as being both social (patient safety) 301 
and individual (personal benefit), as described in Q03. This participant went on to discuss 302 
how workplace culture had influenced him to prescribe suboptimally in certain 303 
circumstances. Although he was aware of how it should be done, the social environment 304 
made suboptimal prescribing acceptable (Table 5, Q10).  305 
 306 
A second participant (Table 4, Participant 06) described why, even though she was aware that 307 
she should complete all the details on a drug chart and ask if she was unsure (self-awareness), 308 
it was not always possible to do so. This was due to a mixture of social factors (affordances, 309 
others’ expectations) and personal factors (avoiding embarrassment/emotions, Table 4, Q04).  310 
Even when she was prescribing individually there was a strong social influence, as she relied 311 
upon guidelines. An affordance refers to the capabilities or support that an environment or 312 
situation offers. When this doctor was by herself, she was afforded the time to look up the 313 
information she needed. In contrast, on ward rounds she simply wrote down what she was 314 
told to (division of labour, others’ expectations, Table 4, Q05):  This doctor went on to talk 315 
about how her own prescribing practice changed over time, due to increased awareness of 316 
why optimal prescribing could benefit her and her peers (self-awareness, personal benefit, 317 
workplace etiquette, Table 4, Q06). 318 
 319 
Prescribing outcomes 320 
Participants’ perceptions of prescribing outcomes could be divided into error, suboptimal or 321 
optimal prescribing. Generally speaking, doctors viewed error as being synonymous with 322 
potential to cause direct and immediate harm to a patient rather than merely writing a 323 
prescription suboptimally (Table 5). One participant explained that avoiding harm to patients 324 
was a strong motivator for good prescribing. She described the difference between forgetting 325 
to check a patient’s allergy status (an individual responsibility) and poor drug monitoring (a 326 
collective responsibility, Table 6, Q12). In doing so, she suggested that the desire to avoid 327 
personal responsibility for harming a patient had a strong influence on prescribing behaviour 328 
(Table 6, Q13). She also emphasised that prescribing errors cause patients to suffer, implying 329 
that a suboptimal prescription that does not cause direct harm to a patient would not be a 330 
"true" error (Table 6, Q14). Another doctor put this more explicitly, stating that some of the 331 
prescribing we identified as suboptimal was not a true error from her perspective. She 332 
recognised the importance of avoiding dangerous prescribing but was less certain about why 333 
suboptimal prescribing was important if it didn’t cause direct harm to patients.  One 334 
participant (Table 5, Q11) rejected feedback about an error, based on the fact that she did not 335 
perceive it as such. From this, we concluded that junior doctors have their own system of 336 
significance regarding errors. 337 
 338 
The junior doctors acknowledged that suboptimal prescribing occurred and that they were 339 
aware of some aspects of their suboptimal behaviour but unaware of others (Table 5). They 340 
perceived suboptimal prescribing differently from error and it was clear that their perceptions 341 
of suboptimal prescribing were not aligned with the criteria we had used to categorise 342 
suboptimal prescriptions (Table 2). Several participants stated that their suboptimal 343 
antimicrobial prescribing behaviour was something they were aware of but they considered it 344 
to be inevitable, acceptable or, in some cases, necessary.  Due to lack of personal knowledge, 345 
some suboptimal prescribing went unrecognised prior to feedback (Table 5, Q07). 346 
Participants stated that some suboptimal prescribing was inevitable, either due to lack of 347 
knowledge about prescribing (Table 5, Q08) or due to the social environment (Table 5, Q09). 348 
Some suboptimal prescribing was thought to be acceptable within workplace culture. One 349 
participant explained that despite being highly motivated to prescribe appropriately and 350 
having the personal knowledge to do so, on occasions he chose not to because of social 351 
influences, such as senior colleagues, nurses’ reactions, the guidelines and lack of feedback 352 
on his suboptimal prescriptions (Table 5, Q10). Sometimes suboptimal prescribing was 353 
viewed as being necessary, due to prioritising patient safety, rather than strictly following the 354 
best practice guidelines (Table 5, Q11).  355 
 356 
Relationship between prescribing behaviour and outcomes. 357 
Based on our findings from the thematic analysis, we developed a model representing the 358 
behaviour of a prescriber whose written prescriptions occur within a spectrum of prescribing 359 
outcomes, from A to E (Figure 2). A is a prescription that is unequivocally wrong, whilst E is 360 
an optimal prescription (according to our evaluation criteria). The area between A and E 361 
represents suboptimal prescribing. The data show that each junior doctor aims to prescribe 362 
within certain parameters, based on their own perception of a minimum acceptable standard 363 
(B) and their personal maximum capability, which is what they perceive to be best practice 364 
(D). Somewhere between these extremes is their typical, or habitual, prescribing behaviour 365 
(C).  Whilst A and E are fixed points, the positions of B, C and D are flexible, and are 366 
determined by interactions between the individual and the social variables mentioned above.  367 
 368 
The lower limit of acceptable prescribing (B) is strongly motivated by avoidance of 369 
immediate harm to patients (Table 6). The doctors also have a personal standard of typical 370 
prescribing, which does not necessarily refer to the best prescription that the prescriber is 371 
capable of. Instead, it refers to what an individual prescriber perceives to be an acceptable 372 
compromise between the many social and individual variables outlined above in Coding 373 
Template 1 (Table 3) and throughout the thematic analysis. The individual’s perception of 374 
best practice (D) refers to their current maximum capability, which could be achieved if the 375 
individual was strongly motivated to achieve their best standard and if contextual conditions 376 
were optimal. This may or may not equate to best practice, depending on whether doctors’ 377 
perception of an optimal prescription is aligned with our evaluation criteria or falls below 378 
actual best practice.  In summary, therefore, a prescription that occurred in the space between 379 
A and B would represent genuine error and one between B and C represents recognised 380 
suboptimal prescribing.  381 
 382 
Feedback intervention 383 
The feedback workshops enabled participants to relate to others and feel reassured that they 384 
were not the only junior doctor who struggled with antimicrobial prescribing (Table 7, Q15). 385 
It also gave them access to specific, personalized feedback that helped them to identify their 386 
strengths and weaknesses and learn from errors (Table 7, Q16). Importantly, participants 387 
valued having time to reflect on how to improve their prescribing behaviour, as the social 388 
context did not usually afford them the opportunity to do this (Table 7, Q17).  389 
 390 
Impact of the feedback intervention 391 
The qualitative data show that feedback workshops changed the parameters of an individual’s 392 
perception of optimal and adequate prescribing, which may have influenced prescribing 393 
behaviour. Referring to the model, two main mechanisms were responsible for this, occurring 394 
singly or together.  The first is by increasing participants' perceptions of best practice (D), 395 
thereby improving their maximum capability and reducing the gap between D and E.  The 396 
second is by increasing the standard of their typical prescribing practice (C), thereby reducing 397 
the gap between C and D (Table 8). The intervention enabled participants to become aware of 398 
previously unrecognised areas for improvement in their practice, which expanded their scope 399 
for development (Table 8, Q18 and Q19). In addition, by highlighting the importance of 400 
improving prescribing behaviour, the intervention seemed to increase doctors’ motivation to 401 
change (Table 8, Q20).  402 
 403 
In summary, our qualitative data showed that a pharmacist-run feedback intervention 404 
influenced the complex web of interconnected influences on junior doctors’ behaviour. This 405 
is explained and explored further in Discussion. 406 
 407 
Discussion 408 
 409 
The normalised rate of suboptimal antimicrobial prescribing to all antimicrobial prescribing 410 
was significantly lower for the intervention group. For both groups, there were few 411 
prescriptions categorised as "not needed" and no allergy-related suboptimal prescribing was 412 
detected.  The difference between the two groups was largely due to differences in 413 
suboptimally written prescriptions rather than the choice of antimicrobial agent. Suboptimal 414 
prescribing that may have had a direct adverse effect on patient care was infrequent.  415 
  416 
Our thematic analysis of the qualitative data showed that individuals’ prescribing behaviour 417 
was influenced by a complex series of dynamic interactions between individual and social 418 
factors. Our interpretation of these findings (summarised in Figure 2) is that junior doctors’ 419 
prescribing behaviour is part of a complex adaptive social system. When we refer to a system 420 
as adaptive, we mean that the system and its agents will co-evolve in response to change. In 421 
viewing the system as complex, we accept that we cannot predetermine the precise influences 422 
and outcomes of any given situation, so the system eludes prospective analysis. Prescribing 423 
behaviour and outcomes (i.e. prescriptions) are the result of a negotiation, or compromise, 424 
between different influences and variables, which will be different for varying situations, 425 
contexts and individuals. The parameters relating to doctors’ personal perceptions of 426 
prescribing standards, identified in our model, represent loose but flexible boundaries, in that 427 
they are individually and socially negotiated and are thus changeable. However, it is possible 428 
to identify attractors, or states, towards which the system may evolve. We suggest that 429 
feedback workshops can act as a positive attractor within this complex system by expanding 430 
the doctors’ potential for optimal prescribing. Change can occur by influencing doctors’ 431 
perceptions of acceptable, typical and best practice, which are the socially and individually 432 
constructed cognitive parameters by which they judge their own prescriptions.  433 
 434 
In light of the complexity of interactions between different influences on junior doctors’ 435 
perceptions and behaviour, it would be unrealistic to assume that our intervention could have 436 
consistent and predictable effects on prescribing practice. In addition, it is possible that 437 
unfailingly prescribing according to what is defined as ‘best practice’ could influence the 438 
system in negative ways. Imagine, for example, a junior doctor who is determined to 439 
complete all the boxes on the prescription chart during a busy ward round, at the expense of 440 
holding up the rest of the team, reducing the amount of time available to review other 441 
patients, angering the consultant and causing themselves embarrassment (see Table 4, Q04).  442 
Would we prefer a junior doctor to prioritise best practice, designed with the hypothetical 443 
average patient in mind, over safe practice for the unique patient they must treat in the 444 
immediate social context (Table 5, Q11)?  445 
 446 
Broom and colleagues22 and Mattick and colleagues23 have recently proposed that suboptimal 447 
prescribing can be logical and realistic when we consider the social context of clinical 448 
workplaces.  This supports our finding that junior doctors often perceive suboptimal 449 
prescribing as being acceptable or necessary within the context of workplaces. Charani and 450 
colleagues also stressed the limitations of best practice by pointing out that, whilst it applies 451 
to the ‘average’ scenario, patients and prescribing situations are more often unique than 452 
average.24  453 
 454 
Our model emphasises the reciprocity between individual and social influences on behaviour, 455 
which interact to determine junior doctors’ perspectives and subsequent actions. Our findings 456 
suggest that junior doctors’ individual development is an ongoing, dynamic process of 457 
adapting to their social experiences; this view is confirmed by Billett’s work on relational 458 
interdependence.25  459 
 460 
Charani and colleagues pointed out that interventions aimed at junior doctors are likely to be 461 
limited due to the dichotomy between organisational expectation and social norms.24 462 
Although we have increased doctors’ awareness of how and why they could improve their 463 
prescribing behaviour (according to criteria determined by organisational expectation), we 464 
have not directly altered the social and cultural rules that exist within workplaces. However, 465 
if prescribing is a complex system of practice, then learning can be viewed as the process by 466 
which this system, and the individuals within it, adapt and evolve.  We propose that, as 467 
members of the social group that is responsible for the majority of hospital prescribing,8 468 
junior doctors could be in a position to facilitate system adaptation if they are adequately 469 
supported to do so by academic and clinical advisors. Giving this responsibility to the most 470 
junior members of the medical workforce may be innovative but our research has shown that 471 
their insights offer a valuable perspective on practice, which can identify long-standing 472 
traditions and workplace cultures that should be challenged and addressed.  473 
 474 
Strengths and limitations 475 
This was a multi method study that evaluated the efficacy of an intervention designed to 476 
improve antimicrobial prescribing amongst junior doctors, as well as exploring what 477 
influences behaviour and how structured feedback may change it. The use of quantitative 478 
assessment and a qualitative process evaluation is the main strength of this study. Brennan 479 
and Mattick recently stated that there is “an urgent need to create educational interventions 480 
that support the development of desirable behaviours in junior doctors” and that “future 481 
research needs to enhance our understanding of what underpins observed behaviour changes, 482 
for example, by including a qualitative process evaluation within quantitative study 483 
designs”.20 To our knowledge, our study is the first example of such research in this field.  484 
 485 
The numbers of new antimicrobial prescriptions identified on census days were surprisingly 486 
low, despite strenuous efforts to maximise data collection.  After the study had been 487 
completed, a point prevalence audit was conducted on a sample of ten wards (five surgical 488 
and five medical), recording the grade of person who had written all prescriptions on that day 489 
or the previous one. In this audit, we identified 77 antimicrobial prescriptions. Of these, 22 490 
would have met the inclusion criteria for our study. In contrast, pharmacists identified a mean 491 
of 4.4 prescriptions (range 1-15) on the census days. Ward based pharmacists stated that this 492 
was due to time pressures, difficulties identifying junior doctors’ signatures, ‘audit fatigue’ 493 
and lack of incentive to participate. Our audit confirmed that unidentifiable prescribers were 494 
an important barrier to data collection, affecting 13 of the 77 prescriptions, as found by 495 
others.26 Another limitation of the data collection was that it was not always possible to be 496 
sure whether a prescription had been written independently, as this is not something that is 497 
routinely documented. Given that the intervention is dependent upon ward based pharmacists 498 
being willing and able to collect data that can be fed back to prescribers, further work is 499 
needed to develop a system that is sustainable in the current busy NHS, outside the context of 500 
a research study. 501 
 502 
The interviews provided sufficient data for an informative qualitative analysis. However, due 503 
to the complexity of prescribing behaviour and the way in which it is influenced by so many 504 
individual and social variables, including feedback, we cannot assume that the prescribing 505 
behaviour illustrated here would be similar elsewhere or at a different time within the same 506 
setting. It is also possible that participants in the intervention group may have spoken to, and 507 
influenced, those in the control group, although interviews with control group participants did 508 
not indicate this. We feel that our primary conclusions are valid, as they are based on a 509 
conceptualisation of behaviour that could apply to many different workplace tasks, settings 510 
and social groups.  511 
 512 
Future work 513 
The participants and the pharmacist facilitator in this study suggested that future work should 514 
aim to increase the quantity of feedback and provide it closer to the time of the prescription 515 
being completed. Further studies could also involve senior doctors and staff from other 516 
disciplines, in order to address aspects of workplace culture and etiquette that appeared to 517 
have a prominent influence on junior doctors’ behaviour. The model that we have suggested 518 
could provide a valuable tool for investigating how junior doctors’ perceptions of prescribing 519 
change for different drugs, different settings or how these perceptions evolve over time. 520 
Furthermore, it provides a framework for considering how practice occurs in relation to 521 
cognitive parameters that are constructed based on complex interactions between individual 522 
and social factors. This could be applicable to aspects of work and workplace learning in 523 
many different fields of study.   524 
 525 
Conclusion 526 
The normalised rate of appropriate prescribing was significantly better in the intervention 527 
group, particularly for prescription writing. Our qualitative analysis showed that the 528 
intervention increased junior doctors’ awareness of how they could improve and appeared to 529 
raise the standard of their habitual prescribing behaviour. We conceptualised junior doctors’ 530 
prescribing behaviour as part of a complex adaptive social system and view the feedback 531 
intervention as a positive attractor within a complex network of behavioural influences. 532 
Interventions that address other factors within the system, such as senior colleagues’ attitudes 533 
and behaviour, may further enhance the potential for better prescribing amongst junior 534 
doctors. 535 
 536 
The data show that suboptimal prescribing is often perceived as being acceptable or 537 
necessary within the complexity of medical practice, by junior doctors and their senior 538 
colleagues. An important question that our analysis raises is: does optimal prescribing, as 539 
perceived by junior doctors, always indicate true best practice? Our data suggest that it could 540 
be time to reconsider our reliance on a narrow view of best practice, which implies that there 541 
is a simple, correct way of doing something, and, instead, focus on teaching junior doctors to 542 
aim for well-informed, thoughtful practice. Such an approach would take account of the 543 
complexity of individuals and the social milieu in which they work and learn.  544 
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  649 
Figure 1.  Outline of activities in feedback workshop 650 
 651 
• Introductions 652 
• Confidentiality briefing – ‘what is said in the room stays in the room’ 653 
• Provision of feedback information 654 
• Group discussion on challenging antimicrobial prescriptions, focusing on 655 
contextual factors that influence their behaviour e.g. interactions with senior 656 
colleagues 657 
• Setting an individual objective for behaviour change to increase 658 
appropriateness of their own antimicrobial prescribing 659 
• Stating a numerical ‘commitment to change’ between 1-10 660 
• Summarising similarities and differences in objectives and commitment to 661 
change 662 
• Close of session 663 
  664 
Table 1. Number of appropriate and suboptimal prescriptions, shown as independent or 665 
dependent prescriptions, for the intervention and the control group.  666 
 667 
 Intervention 
n (%) 
Control  
n (%) 
All  
n (%) 
Appropriate Independent  20 (26.7%) 18 (13.9%) 38 (18.6%) 
Appropriate Dependent 17 (22.7%) 33 (25.6%) 50 (24.5%) 
    
Suboptimal Independent  20 (26.7%) 36 (27.9%) 56 (27.5%) 
Suboptimal Dependent 18 (24.0%) 42 (32.6%) 60 (29.4%) 
    
Total 75 129 204 
 668 
 669 
  670 
Table 2. Number of appropriate and suboptimal prescriptions, categorised by type, for the 671 
intervention and the control group.  672 
 Intervention  Control  
Appropriate antimicrobial prescribing    
Choice/use based on recognised best practice  37 (49.3%)  51 (39.5%)  
Suboptimal choice of antimicrobial medication    
Not needed 2 (2.7%) 3 (2.3%) 
Not followed Trust/other guidance 5 (6.7%) 8 (6.2%) 
Suboptimal choice for patient due to age etc  0 1 (0.8%) 
Suboptimal writing of prescription    
Sub-optimal regimen  31 (41.3%) 62 (48.1%) 
Sub-optimal or no duration  0 4 (3.1%) 
Overall total  75 (100%) 129 (100%) 
  673 
Table 3. Coding Templates 1 and 2. 674 
Coding Template 1: Influences on Prescribing Practice 
First-level code Second-level code Third-level code 
Prescribing behaviour Prescribing process 
 
Personal 
knowledge/experience (I) 
Habits (I) 
Agency (I) 
Self-awareness (I) 
Emotions (I) 
Instructions from others (S) 
Division of labour (S) 
Affordances (S) 
Resources/guidelines (S) 
Workplace culture/etiquette 
(S) 
Motivation Personal benefit (I) 
Others’ expectations (S) 
Patient safety (S) 
Best practice (S) 
Evaluation Self-assessment (I) 
Feedback (S) 
Prescribing outcome (the 
written prescription) 
Error   
Suboptimal – recognised or 
unrecognised 
Optimal prescribing  
Coding Template 2: Impact of Feedback Intervention 
Feedback intervention Relating to others Peer group learning 
Reassurance 
Informed self-assessment Learning from errors 
Identification of weaknesses 
Reflection on feedback Rejection of feedback 
Trigger for behaviour change 
Behaviour  change  
 675 
I=individual influence; S=social influence 676 
  677 
Table 4. Case examples of prescribing behaviour from the qualitative data.  678 
 679 
Number Quote 
 Case 1 – Participant 04 
Q01 “Sometimes being unaware of how long you should keep somebody on 
something, because even though the guidelines state so-and-so days, if you phone 
a microbiologist they may say to go longer or shorter, and then your consultant 
who’s very experienced might say only keep them on that for three days, don’t 
keep them on longer.”  
Q02 “I heard from a consultant before that so much money is being spent on different 
drugs but hardly anything's been spent on new antibiotics, and we haven't really 
got a new generation of antibiotics being brought in, so these are the antibiotics 
that we have now and if we waste them and do get resistances then that's bad 
news for us… …Some people have a blasé attitude about that. It’s very easy to 
just fall into being equally blasé. So I suppose I don't like being like that. I like 
being smart about things… … You usually have weekly updates on how we’re all 
going to die because of some horrible bug on BBC One. So [I’m] influenced by 
the media and by my seniors basically” 
Q03 “I think if someone’s on Tazocin too long you always want to review them after 
48 hours. If they’re apyrexial, take them off. Even if it is just for the reason that 
you don’t want to have to keep on cannulating them, because you should always 
try and switch them on to orals as quickly as possible for their benefit, but it also 
benefits you because you don’t have to faff around…” 
 Case 2 – Participant 06 
Q04 “I do try to always make sure I write those things [dosage, duration] on, but as 
an F1 [Foundation Year 1 doctor], sometimes you’re just told what to prescribe 
by whoever, your senior, and it’s not always clear what the indication is 
sometimes, and sometimes you don’t want to ask because you look a bit stupid if 
you don’t know, like, why they’ve chosen that antibiotic…I should probably ask, 
but sometimes you don’t have time, or sometimes you think, maybe I just wasn’t 
listening when he said what it was for, so, I don’t want to look stupid and ask 
him.”  
Q05 “Prescribing by myself is normally… I’ll know why I want to give the antibiotics, 
or if I don’t, like, sepsis query source that’s fine because I know that there’s a 
guideline for it, the formulary for the hospital, so that makes it much easier.  
Then I can look up that because I’m by myself and I’ve got time to, to look up 
how long it should be and what it should be.  So, that’s easier if it’s by myself, 
but if I’m on ward round and someone just tells me to write something up, that’s 
probably when less things get filled in, if they’re not telling me what to put in it.” 
Q06  “[When I first started] I didn’t really see the importance of it [writing the 
clinical indication on the prescription].  Now, because I’ve done loads of on 
calls, I can see the importance of how it’s useful… …I think it doesn’t really 
matter to the patient whether clinical indications are written on there if they’re 
getting the right antibiotic.  I think it makes it easier for other doctors coming in 
to look at it.” 
  680 
Table 5. Participants’ explanations of suboptimal prescribing. 681 
Number Quote 
Q07 Participant 10: “The first job I was in it [prescribing] wasn’t really pointed out 
as a problem but during the study it was.  I got to know that I was prescribing 
Tazocin.” 
Interviewer: “So that was something you just hadn’t realised you were supposed 
to do differently?” 
Participant 10: “Yeah.” 
Q08 Participant 02:  “I was always conscious, at the back of my head, of the lack of 
microbiology teaching that I received in medical school anyway, and based on 
that, the fact that my knowledge in this area is deficient…It was a bad basis for 
antimicrobial prescribing, the fact that our microbiology teaching was not sub-
optimal, it was absent.  It was non-existent… …That formed the bad basis for 
antimicrobial prescribing.”   
Q09 Participant 08: “Surgical ward rounds post take are so fast you don’t even 
know if you’re coming or going and, you know, you’re writing in someone else’s 
notes whilst they’ve gone on to the next patient and you’re expected to prescribe 
the medication.  So, yeah, you know, you often...that is tricky so you do...they’re 
those prescriptions that might not be as good as you’d like them to be.” 
Q10 Participant 04: “I’ll still prescribe Tazocin because someone will just say 
Tazocin, and all my colleagues just write Tazocin, and it’s just 
Tazocin…everyone else does it so you do it…you actually have that written as 
Tazocin on the antimicrobial [guidelines]…maybe that’s why I’ve been 
influenced…I always feel like a bit of a geek when I prescribe it [piperacillin and 
tazobactam]…It’s almost like you’re writing it in a very formal way but you 
don’t need to because they all know. It’s almost like they [the nurses] look at you 
as if you’re insulting their intelligence…You need to inform the consultants, the 
registrars to call it piperacillin and tazobactam and encourage it from that point 
of view so that juniors get into good habits at the start…If you write Tazocin and 
then nothing comes of it and there’s no adverse effects you think wow, well I can 
just write Tazocin every day.” 
Q11 Participant 01: “I think that [prescribing a lower dose] was appropriate 
anyway because I don’t want to give a higher dose risking overdose rather than, 
you know, I just always think it’s safer to give a lower dose in that case ... I think 
in that situation I would perhaps still prescribe as I wouldn’t think it’s dangerous 
or anything like that. If anything I think it’s safer than prescribing the higher 
dose to a renal impaired patient.” 
 682 
  683 
Table 6. Participants’ perceptions of error. 684 
 685 
Number Quote 
Q12 Participant 06: “[Checking allergies is] such a simple thing to do, and if you 
get it wrong, like it’s…instead of you giving a treatment that’s going to help 
somebody, you’ve actively made them worse, and that’s your prescribing.  I think 
that’s…I mean, I’m not…like giving someone C. diff, and giving them antibiotics 
for 20 days is obviously horrendous as well, but there will have been people that 
have looked at that every day, not just you, and seen it was going on for 20 
days.” (patient safety, motivation, emotions) 
Q13  Participant 06: “The less mistakes I can make, the better, because obviously, it 
is always the patient that suffers”(patient safety) 
Q14 Interviewer: “Maybe some of what was classed as inappropriate prescribing 
wasn’t a prescribing error from your point of view? 
 
Participant 01: “Yeah, I think there is a grey area as well a lot of the times in 
antimicrobials so I think you really need to...yeah, I don’t know, I think it 
depends on the percentage of dangerous prescribing.  Hopefully there isn’t 
any.”(patient safety) 
 686 
  687 
 688 
  689 
Table 7. Participants’ views on the impact of the intervention.  690 
Number Quote 
Q15 Participant 02:  “Just a feeling of relief that most of us junior doctors are pretty 
much in the same boat, it’s not just me that is a bit oblivious to certain aspects of 
antimicrobial prescribing!...That’s one of the things I appreciate the most of this 
intervention …[I’m] not really different from other junior doctors.” 
Q16 Participant 10:  “Yeah, I think it’s good to see what you’re doing well and what 
you’re doing badly like individually, you know, because I think a lot of the time 
there’s a focus on not singling people out on the wards and saying you’re doing 
that wrong.  And I think it’s a good thing to do really.” 
Q17 Participant 08:  “When you’re on a ward round and you’re filling out the form, 
it was more seen as a chore and obviously it would flag things up in your mind 
but then you’re on to the next thing, whereas this [the intervention] makes you 
actually sit down and think about it, talk about it and reflect on it.” 
 691 
  692 
 693 
Table 8. Mechanisms of behaviour change.  694 
Number Quote 
Q18 Participant 02:  “I would find out the duration if I’d been asked to prescribe, 
indication…so yes, and also when I am referring to resources, particularly when 
I’m discussing the case with the microbiologist, I would ask, for my own learning 
experience, to address the knowledge deficiency…just say, for my own learning, 
why this antibiotic and why not the other one.” 
Q19 Participant 10:  “I suppose it was just interesting to hear what, from a 
pharmacist’s point of view and generally from the records point of view, what 
was wanted of us when we write an antibiotic prescription in terms of being as 
specific as you can possibly be about why you’re giving it, the duration of it.” 
Q20 Participant 09:  “[The ward round] goes so fast and you’ll often just get told to 
prescribe something and you’re not sure yourself why so you leave that box 
blank because you don’t want to look like an idiot and say, why are we starting 
this? But I’m just going to question anyway so I can get it right…you might just 
get a bit of a telling off or a ‘you should know’, but that’s life isn’t it.” 
 695 
Figure 2. A model of junior doctors’ prescribing behaviour 

 
